APA (7th ed.) Citation

Malvaso, D., Calabrese, L., Chiricozzi, A., Antonelli, F., Coscarella, G., Rubegni, P., & Peris, K. (2023). IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa. Pharmaceutics, 15(10), 2450. https://doi.org/10.3390/pharmaceutics15102450

Chicago Style (17th ed.) Citation

Malvaso, Dalma, Laura Calabrese, Andrea Chiricozzi, Flaminia Antonelli, Giulia Coscarella, Pietro Rubegni, and Ketty Peris. "IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa." Pharmaceutics 15, no. 10 (2023): 2450. https://doi.org/10.3390/pharmaceutics15102450.

MLA (9th ed.) Citation

Malvaso, Dalma, et al. "IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa." Pharmaceutics, vol. 15, no. 10, 2023, p. 2450, https://doi.org/10.3390/pharmaceutics15102450.